HIKMA PHARMACEUTICALS USA INC.

LABETALOL HCL

  1. Home
  2.  / 
  3. J Code
  4.  / LABETALOL HCL – J1921

Manufacturer:

HIKMA PHARMACEUTICALS USA INC.

Name:

LABETALOL HCL

HCPCS Code Descriptor:

Injection, labetalol hydrochloride (hikma) not therapeutically equivalent to j1820, 5 mg

Category:

J Code

HCPCS:

J1921

NDC(s):

00641-6252-10, 00143-9623-01, 00143-9622-01, 00143-9363-10, 00143-9364-10, 00143-9366-10, 00143-9365-10, 00143-9320-01

Primary Type:

Cardiology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

LABETALOL HCL is a Cardiology drug manufactured by HIKMA PHARMACEUTICALS USA INC. and administered via the Intravenous route of administration. The J Code: J1921 is aligned to the drug LABETALOL HCL.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Inj labetalol hcl hikma, 5mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found